Ethyl 5-(oxan-4-yl)-1,3,4-oxadiazole-2-carboxylate, 1g

2-(4-Formyl-2-methoxyphenoxy)-N,N-diphenylacetamide, 5g

Myricitrin, 91%, 5g

(R)-1-(6-Methoxy-2-methylsulfanyl-pyrimidin-4-yl)-pyrrolidin-3-ol, 95.0%, 250mg

monoclonal de ratón anti-Sinaptopodina/SYNPO, G1D4, 0,2 ml

(4-(N,N-Diethylsulfamoyl)-2-methylphenyl)boronic acid, 95.0%, 250mg

3-Ethoxy-2-hydroxybenzaldehyde, 95.0%, 5g

1,3,5-Tris(4-bromonaphthalen-1-yl)benzene, 5g

Ethyl 3-Aminopyrazole-4-carboxylate>98.0%(GC)(T)5g

Marcador permanente, edding®, 404, azul, punta redonda extrafina, 0,75 mm 10 piezas

Boc-Leucinol, 97%, 10g

3-Fluorocinnamic Acid>98.0%(T)5g

tert-Butyl 4-(3-methyl-4-nitrophenyl)piperazine-1-carboxylate, 95.0%, 2g